BIT's 17th Annual Congress of International Drug Discovery Science and Technology (IDDST-2019)
Scientific Program
Scientific Program
Stream 1 Stream 2 Stream 3 Stream 4 Stream 5


Stream 2: Drug Discovery S & T

Stream 2-1: Frontiers in Drug Discovery Science
Stream 2-2: Innovative Drug Discovery Technologies


Stream 2-2: Innovative Drug Discovery Technologies


Session 221: Innovative Drug Discovery Technology

Day 1: Afternoon, Thursday, July 25, 2019

Place: Room G, 1st Floor

Chair: Dr. Kiyoshi Nokihara, CEO, HiPep Laboratories, Japan

Co-Chair: Dr. Ping Yang, CEO & Chairman, Synbio Technologies LLC, USA
Time Speeches and Speakers

Chair’s Introduction



Title: Advantages of Applying a New Biophysical Approach to HTS for Lead ID, Lead Validation and Optimization

Dr. Rene Wink, Technical Sales and Application Specialist, NanoTemper Technologies GmbH, Germany


Keynote Speech
Title: Developing and Integrating Novel Drug Discovery Technologies for Screening, Validation and Profiling of Synthetic and Biologics Modalities
Dr. Alexey Rak, Director of Bio Structure and Biophysics, Integrated Drug Discovery, Sanofi R&D, France


Title: The LEO Science & Tech Hubs: Exploring Cutting-edge Science and Technology in Dermatology

Dr. Tord Labuda, Vice President, R&D Asia-Pacific Hub, LEO Pharma K.K., Japan


Title: Novel Antibody Discovery through DNA Approaches

Dr. Ping Yang, CEO & Chairman, Synbio Technologies LLC, USA


Title: Discovery of Drugs by Using Immobilized-cyclotides on Gel-type Beads and Improved Deconvolution Method

Dr. Kiyoshi Nokihara, CEO, HiPep Laboratories, Japan


Coffee Break


Title: New Paradigms for the Treatment of Infectious Diseases, Role of Drug Discovery

Dr. Domingo Gargallo-Viola, CSO, ABAC Therapeutics, Spain

16:00-16:20 Title: Degradation of Target Proteins by Small Molecules
Dr. Minoru Ishikawa, Professor, Tohoku University, Japan

Title: Ring Distortion of Indole Alkaloids: A New Platform for Drug Discovery

Dr. Robert Huigens, Assistant Professor of Medicinal Chemistry, University of Florida, USA


Title: Insulin Degludec: An Intervention to Reduce Glycemic Variability

Dr. Diana Cristina Henao Carrillo, Professor of Endocrinology, Hospital Universitario San Ignacio – Pontificia Universidad Javeriana, Colombia


Title: Novel Technology of Synthesizing Commercial Available Drugs with Intrinsic Magnetism
Dr. Masanari Umemura, Lecturer, Cardiovascular Research Institute, Yokohama City University, Japan


Session 222: Novel Detection and Analysis Technologies and Instruments in Drug Discovery

Day 2: Morning, Friday, July 26, 2019

Place: Room H, 1st Floor

Chair: Dr. Anthony W. Coleman, Research Director, Université de Lyon, France

Co-Chair: Dr. Udo Klotzbach, Fraunhofer Institute for Material and Beam Technology, Germany

Time Speeches and Speakers

Chair’s Introduction


Title: Supramolecular Epigenetics: The Vital Role of Magnesium
Dr. Anthony W. Coleman,
Research Director, University of Lyon, France


Title: Chiral HPLC Resolution of a Potentially Serious Global Health Crisis

Dr. Clydewyn M. Anthony, Senior Scientific Liaison, The United States Pharmacopeial Convention, USA


Title: Total Analysis of Absolute NMR Shielding for Biologically Active Chemical Compounds. Theory and Experiments
Dr. Karol Jackowski, Head of NMR Laboratory, University of Warsaw, Poland


Title: Toward Better Understanding of Physical Stability of Amorphous Drugs

Dr. Marian Paluch, Professor, University of Silesia, Poland

09:55-10:15 Title: Use of Plasmon Waveguide Resonance (PWR) Spectroscopy to Study Selective Cellular Signaling in G-protein Coupled Receptors in Response to Ligands
Dr. Minying Cai, Professor, Department of Chemistry & Biochemistry, University of Arizona, USA

Coffee Break


Title: Microphysiological Organ-on-a-chip Systems as Interdisciplinary Platforms for SMEs, Big Pharma, Physicians and Technologists
Dr. Udo Klotzbach, Fraunhofer Institute for Material and Beam Technology, Germany


Title: Microfluidic Models of Pancreatic Tumors to Assess Therapeutic Strategies

Dr. Vincent Senez, Senior MEMS Research Scientist, University of Lille, CNRS/U-Tokyo LIMMS UMI 2820, France


Title: Atorvastatin as a Promising Crystallization Inhibitor of Amorphous Probucol: Dielectric Studies at Ambient and Elevated Pressure

Dr. Justyna Knapik-Kowalczuk, Assistant Professor, Institute of Physics and SMCEBI, University of Silesia, Poland


Title: Retention and Selectivity of Cogent Hydride Based Stationary Phases in Hydrophilic Interaction Liquid Chromatography (HILIC)

Dr. Eman Y. Santali, Assistant Professor, Taif University, Saudi Arabia

11:50-12:10 Panel Discussion




© 2003-2019 All rights reserved by BITeomics
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84796897